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ABSTRACT

Williams, Bradley Allen. M.S.., Department of Pharmacology & Toxicology,
Wright State University, 2013. Locating Chelerythrine, an Alkaloid, Within a
Cytosolic Environment via MALDI-TOF Mass Spectrometry.

The quaternary benzo-phenanthridine alkaloid (QBA) chelerythrine (CET)
is a well-known inhibitor of PKC and cancer growth (Herbert et al., 1990). In human
lens epithelial cells (HLECs), CET almost completely inhibits the Na+/K+ pump
ATPase (NKA) without changes in phosphorylation (Lauf et al. 2013). Protein
alignment studies revealed B-lymphocyte type 2 protein (Bcl-2) BH1- like motifs
within the α1 subunit of the NKA to which CET, a drug mimicking Bcl-2 protein
BH3-like motifs, might bind thus disrupting NKA function (Lauf et al, 2013). It is
unknown by which mechanism CET crosses the plasma membrane to reach its
intracellular targets, especially the NKA. In solution, CET exists in two forms, as a
positively charged and as uncharged monomer or pseudo-base. The hypothesis is
that CET crosses the plasma membrane as monomer and, in the slightly acidic
cytosol binds as the positively charged drug to its putative sites on the NKA and
pro-survival BcL-2 proteins. The objective of this work is to track the alkaloid CET
via MALDI-TOF Mass Spectrometry from the external media bathing HLECs into
the cytosol and plasma membrane, if possible into the NKA. A prerequisite of this
project is to gain insight into how CET behaves in the biological solutions used,
how it might cross the plasma membrane normally impermeable to charged drugs,
and how the lower pH within the cytosol affects the ratio of the charged to
iii

uncharged species of CET. Once evidence is brought forth that CET reaches the
plasma membrane, future studies will address by mass spectrometry, the
interactions of CET with the NKA during its canonical operation, and perhaps
isolate the CET binding site (s) within the NKA.
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INTRODUCTION
Background of Chelerythrine (Sanguinaria Canadensis)
Chelerythrine (CET) is a colorless crystalline poisonous alkaloid of 348
Dalton (Da) mass obtained from Celandine (Chelidonium majus Linneaus) and
other papaveraceous plants forming yellow salts with a violet fluorescence.
Chemically, CET is a benzo-phenanthridine with 4 benzene rings, 1 dioxanol ring,
2 methoxy groups and depending on pH, a positively charged imminium at position
5 of benzene ring B.

Papaveraceae
(Poppy Family)
Over 600 Species

Cheledonium
Majus

Chelerythrine w/ Cl-

Chelerythrine

Sanguinarine

Sanguinarines, derived from Sanguinaria Canadensis bloodroot, is a perennial,
herbaceous flowering plant native to eastern North America. It has essentially the
same structure as CET but instead of the two methoxy residues in C7 and 8 it has
1

another dioxanol ring. It is the only species in the genus Sanguinaria in this
Hemisphere that is included in the family of Papaveraceae, and most closely
related to Eomecon of Eastern Asia. Chelerythrine chloride used here, is an antiplatelet agent isolated from Zanthoxylum simulans.
Potential Applications of Chelerythrine
Chelerythrine (CET) isolated from Zanthoxylum simulans has been studied
for its use as an anti-platelet, anti-inflammatory, antibacterial antitumor drug, as a
pro-apoptosis agent and inhibitor of PKC (Alacantra, 2005) (Barrett, 2011).
A recent publication (Lauf et al. 2013) shows that CET inhibits the Na +/K+
pump ATPase or NKA like sanguinarines with an IC 50 of 20-30 μM. Based on the
finding that CET may exert its pro-apoptotic function by binding as a BH3-mimetic
drug to a BH1 motif, a specific sequence of amino acids within the pro-survival Bcl2 protein BclXl, at least two putative BH1-like motifs were found within functional
domains of the NKA through which the drug may alter its activity (Lauf et al. 2013).
However, direct structure-function evidence for binding of CET to NKA still needs
be established.
Toxicity of Sanguarines
Bloodroot produces benzylisoquinoline alkaloids, primarily the toxin
sanguinarine which has similar structures to that of codeine and morphine. The
alkaloids are transported to and stored in the rhizome. Comparing the biosynthesis
of morphine and sanguinarine, the final common intermediate is (S)-reticuline. A
number of plants in Papaveraceae and Ranunculaceae, as well as plants in the
genus Colchicum (family Colchicaceae) and genus Chondodendron (family
2

Menispermaceae), also produce such benzylisoquinoline alkaloids (Alacantra et al
2005) (Reference Pathway).
Sanguinarines, of similar structure as CET, inhibit the NKA by mechanisms
also undefined at this time (WEISS et.al 2006; Alacantra et al 2005; Barrett et al
2011). Numerous in vitro and in vivo studies have demonstrated that sanguinarine
causes apoptosis in human cancer cells, suggesting future development of
sanguinarine as a potential cancer treatment. Historically, the bark of the
Zanthoxylum simulans tree, from which CET is extracted, was used to treat
rheumatism and tooth aches. Due to its anti-leuko-plaque functions, CET was
earlier incorporated in some toothpaste.
Modern Day Uses
Apart from the scientific and chemical uses for CET, it also has been used
in culinary recipes as an Asian Foods spice known under the name as Szechuan
pepper.
Significance
With the suggested role of CET it is easy to foresee many medicinal and
pharmacological advantages from preventing the manifestation of the Herpes
Simplex Virus infection, the onset of Methicillin Resistant Staphylococcus Aureus
(MRSA) invasion, and attenuating cellular proliferation in cancer (Monavari et. al
2011; Zhao et. al 2003). While it appears and has long been thought that CET
inhibits PKC only, new studies are warranted to track the cytosolic binding site for
CET and how it inhibits PKC.
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If indeed, as determined by current technology, PKC is directly inhibited, as
Herbert et al. described in 1990, then this drug may prove to be a beneficial tool
against diseases such as MRSA, HSV, etc. Due to this potential of CET alone, and
the fact that NKA is inhibited by CET and thus cellular ionic equilibria are perturbed,
it is important to track its location into the cytosol.
Cell Membrane
The cell membrane, also known as plasma membrane, is defined as the
outer covering of the cell consisting of a lipid bilayer with proteins embedded in it
as proposed in the so called fluid mosaic model (Singer et al 1970) The membrane
separates the inside of the cell from the outside environments and is a
phospholipid bilayer interspersed with proteins. Its structure and composition
makes it semi-permeable for water and selectively permeable for solutes, which
does not means every substance is allowed to enter or leave the cell at equal rate
(Cell Membrane).
Phospholipids are amphiphiles with the hydrocarbon tail of the molecule
being hydrophobic; and their polar heads hydrophilic. As the plasma membrane
faces watery solutions on both sides, its phospholipids accommodate this by
forming a phospholipid bilayer with the hydrophobic tails facing each other, the so
called hydrophobic effect (Tanford 1980). Substantial amounts of cholesterol are
tucked within the hydrocarbon tails.
The cell membrane controls which substances can go in and out of the cell.
It can allow a particular substance to pass through at a certain time, and then reject
the same substance at a later time. Cell membranes are involved in a variety of
4

cellular processes such as cell adhesion, ion conductivity and cell signaling and
serve as the attachment surface for several extracellular structures.
Cell Permeability
Cell permeability is defined as the property of cell membranes which permits
the passage of solvents and solutes into and out of cells. The ability for a
compound to cross the cell membrane depends on three factors; molecular weight,
lipid solubility and molecular charge. Small molecules and lipophilic compounds
can usually cross with ease. The cell can control many factors of its membranes,
including permeability (Cell Permeability 2002).
Control can be exerted in the following ways: (1) by varying the number and
variety of membranes; (2) by varying the specific nature of the lipid components in
the membrane; (3) by varying the glycocalyx proteins or lipid-associated sugar
molecules on the outside of the cell, or the membrane-associated proteins on the
inside; (4) by causing large areas of membrane to flow from one place to another,
or to fold, indent, evert, or pinch off, carrying with these movements substances
bound to one or the other surface of the membrane, or embedded in it; (5) by
selectively moving integral membrane proteins in the plane of the membrane,
allowing these proteins to carry with them substances, particles, molecules, or
other materials bound to them; (6) by varying the properties of a single integral
membrane protein or of a closely associated group of them so as to allow or
prevent the passage across the membrane of substances such as ions or proteins
of a specific character (Cell Permeability 2002).
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Human Len’s Epithelial Cells
Crystalline lens consists of epithelial cells, fiber cells, and a capsule. They
originate from lens epithelial cells. Epithelial cells differentiate into fiber cells and
produce collagen, which is the major compound of the capsule. The lens epithelial
cells maintain normal physiology and homeostasis of the lens, so the cultures of
human lens epithelial (HLECs) cells provide important information concerning the
role of epithelium in normal and cataract formation (Ibaraki et al 1998).
Hypothesis
The hypothesis is proposed that CET crosses the plasma membrane as a
monomer, and appears as a positively charged monomer within the cytosolic
micro-environment to bind to Bcl-2 proteins and Na+/K+ pump ATPase (NKA)
through putative cytosolic BH1-like sites resulting in NKA inhibition and apoptosis
This thesis focuses on the effects of CET at the cellular level, its mechanism
and to track by MALDI-TOF Mass Spectrometry the cellular location of CET
associated with the functional knockout of the NKA in human lens epithelial cells
(HLECs) with three specific aims:
1. Establish the presence of charged and uncharged CET monomers and
ether-bonded CET dimers in organic solvents, and determine in aqueous
solutions of varying pH the apparent pK value of the transitional charge of
the imminium bond.
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2. Establish a calibration curve of peak intensity versus m/z ratio of CET at
defined pH values at which either the charged or the uncharged monomer
prevails in aqueous solution. This calibration curve permits to calculate
unknown concentrations in biological extracts from HLECs previously
exposed to CET.
3. Track the alkaloid CET diffusion from the external solution phase into the
cytosol and the membrane fractions of HLECs and determine its quantities
by using the calibration curve established in aim 2. Calculate the measured
quantities in moles/L cytosol and moles/g protein and compare solution
numbers with estimates that are based on predictions made by the NernstPlanck equation for cells with given membrane potentials.
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MATERIAL AND METHODS
MALDI-TOF Mass Spectrometry
Matrix-Assisted Laser Desorption/Ionization (MALDI) is a soft ionization two
step technique used in mass spectrometry that allows analysis of biomolecules
and large organic molecules. Desorption is first triggered by a laser which leads to
ablation (blasting of the topmost layer) and forms a hot plume in which the
molecules are ionized (protonated/deprotonated). The ionized molecules then
travel into a vacuum to a detector.
Time of Flight (TOF) is a method of Mass Spectrometry in which the ion’s
mass to charge ratio (m/z) is determined by measuring the time it takes for the
charged or uncharged particle to reach a detector. Heavier particles have lower
speeds while light particles travel fast.
The “matrix” used in MALDI consists of crystallized molecules which assist
the ability of the ions to “fly” during ablation into the vacuum. The most common
matrixes used in MALDI are (CHCA) α-cyano-4-hydroxycinnamic acid, 2, 5dihydroxybenzoic acid (Lot# NI174946, Prod # 90031, Thermo Scientific and Acros
Organics), and (DHB) 3, 5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid). The
matrix was combined with the sample and spotted on a MALDI-TOF brushed steel
plate (s/n03557, Bruker Daltonics). After trial and error the best matrix in
combination with CET was CHCA.
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Mass Spec Sample Preparation:
Chelerythrine Stock Solution: A solution of 770 µg of Chelerythrine chloride
(frozen) was made in 100 µl of 50 % acetonitrile (ACN) containing 0.1 %
trifluoracetic acid (TFA) in a 2 mL microfuge tube and vortexed for one min. CET
was mixed with 1 µL of matrix (10 mg/mL CHCA or DHB in 50% ACN in 0.1% TFA)
solution and spotted on a MALDI-TOF mass spectrometry Brushed Steel plate and
run for analysis. The concentration of CET used from this stock solution was 2.2
mM as determined by: mM = 770 mg CET/100 µL solution/ 348.37 g/mol CET.
Another stock solution of 9 mM CET was later made based on the reported molar
extinction coefficient of 29066 dm3mol-1cm-1 at 315 nm (Dorney et al., 2013).
Matrix Solution Preparation: Two matrix solutions, DHB and CHCA, were used
to test for the best results with CET. Matrix was made by mixing 10 mg of CHCA
or DHB with 1 mL of 50 % ACN in 0.3 % TFA, followed by vortexing for one min.
Upon much trial and error between the two matrixes, it was determined that for the
purposes of CET, α-cyano-4-hydroxycinnamic acid (CHCA) allows ions to be
analyzed more accurately.
Logarithmic CET Dilutions: The purposes of the logarithmic dilutions (Table 1)
were to determine: a) the optimal matrix for use with CET and b) whether the
monomeric peak was solvent-dependent. CET was diluted in 50 % ACN in 0.1 %
TFA. Further dilutions (1:10) were made from this stock solution. Each dilution was
vortexed to ensure thorough mixing. From the calibration curve, it was established
that the concentration of CET is 2.2 mM.
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The logarithmic dilution of CET was utilized to form a calibration curve as
stated in Specific Aim II (establish by MALDI-TOF Mass Spectrometry a calibration
curve of peak intensity versus m/z ratio of CET at defined pH values at which either
the charged or the uncharged monomer prevails in aqueous solution). This was
needed to calculate unknown concentrations in biological extracts from HLECs
previously exposed to CET.
Predicting the Mass Presence of the Monomer Serial dilutions of CET were
conducted using 1 μL CET ten-fold diluted in 9 μL of ACN. Samples were then
mixed with 1 μL of matrix CHCA and spotted to a brushed steel MALDI-Target.
The spots were blasted with a laser at intensity of approximately 80 and a gain of
4 in reflector mode. 10,000 laser shots were captured from each spot and the
spectra analyzed between 100-2000 Da.
Establishing a Calibration Curve Serial dilutions of CET were conducted using
1 μL CET and preparing ten-fold dilutions (1:10) in 9 μL of ACN. Samples were
then mixed with 1 micro liter of matrix CHCA and spotted to a brushed steel MALDITarget. The spots were blasted with a laser at intensity of approximately 80 and a
gain of 4 in reflector mode. 10,000 laser shots were captured from each spot with
the spectra being analyzed between 100-2000 Da.
Tracking CET within the Cytosolic Domain Supernatant cytosolic and
membrane fractions were collected from HLECs before and after exposure to 50
μM CET for direct analysis (as detailed in Dorney et al. 2013). Samples were then
mixed with 1 μL of matrix CHCA and spotted to a brushed steel MALDI-Target.
The spots were blasted with a laser at intensity of approximately 80 and a gain of
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4 in reflector mode. 10,000 laser shots were captured from each spot with the
spectra analyzed between 100-2000 Da.
Tandem Mass Spectrometry
A tandem mass spectrometer is also known as a MS/MS or MS 2. It is an
arrangement in which ions are subjected to two or more sequential stages of
analysis according to quotient mass/charge ("Tandem Mass Spectrometer”). This
instrument combines the advantages of high sensitivity for peptide analysis
associated with MALDI and comprehensive fragmentation information provided by
high-energy collision-induced dissociation (CID) (Medzihradszky et al. 2000).
Some of the advantages of tandem mass spectrometry are more powerful
structure elucidation, and selective detection of a target compound. It greatly
reduces interferences and allows for the study of ion-molecule reactions (Uggerud
et al 2003). These advantages help with identifying the monomer peak when trying
to locate it in cytosolic solutions. Background noise can be reduced by focusing on
one peak and by fragmenting that peak, establish a fingerprint. The fingerprint is
believed to be specific enough for identification solely by the comparison of the
mass values (Florence et al 2003).
Ion Trap Mass Spectrometry
The Quadruple Ion Trap or Quadruple Ion Storage Trap (QUISTOR) exists
in both linear and 3D varieties and refers to an ion trap that uses constant DC (nonoscillating, static) and radio frequency (RF) oscillating AC electric fields to trap ions
commonly used as a component of a mass spectrometer (March et al., 2000).
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The ions are first pulled up and down axially while being pushed in radially.
In this way the ions move in a complex motion that generally involves the cloud of
ions being long and narrow and then short and wide, back and forth, oscillating
between the two states (Stafford et al 1984).
The procedure for conducting the ion trap experiment includes obtaining a
2 mL microfuge tube. Into the microfuge tube, 0.3 % of 10X formic acid (Prod #
28905, LOT# JF123846, Thermo Scientific), 70 % ACN, and 29.7 % of CET stock
were added (87 μL CET in

ddH20;

210 µl 70 % ACN; 3 µl 10X formic acid). This

solution was then vortexed for ~1 min for homogeneity.
The benefit of the Ion Trap for this thesis is providing extra confirmation of
the monomer parent peak and its fragments. In Figure 11, there are identical
fragment peaks that were found when the tandem mass spec was conducted. The
benefit of the ion trap is that, unlike mass spectrometry, no matrix is needed.
Analysis is conducted directly on the compound itself.
To test for the pH-dependent monomer transition, a CET stock of 50% ACN
in 0.1 % TFA was diluted in 0.1 N HCl or in 0.1 N NaOH and vortexed to ensure
thorough mixing as listed in Table 2A and B
Solvent Dependent Serial Dilutions
This experiment followed the procedure of serial dilutions of CET, however, the
solvent used and stocks were switched as shown in Table 1.
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Table 1:
CET Stock ACN

CAN

dH20

dH20

ACN

Can

dH20

Can

dH20

HCl

NaOH/

used
Solvent

ACN

used

dH20

The rationale of this experiment rests on the reported pH-dependent
solution equilibrium between the charged monomer and the uncharged pseudo
base of CET (Malikova et al. 2006) The charged form of CET is due to uneven 
electron distribution between the nitrogen in position 5 and the carbon in position
6 of the of the B-benzene ring of CET, creating the positively charged iminium
group which attracts small anions such as chloride (Cl). Upon alkalization the
charged form converts into the uncharged pseudo base (hydroxylation of C6) or
under extreme conditions forms an ether between two monomers (Malikova et al.
2006).
In order to study the possibility of charged monomer to uncharged pseudo
base transition, and hence the possibility of peak intensity changes as function of
pH, serial dilutions were performed with acids and bases. This approach was to
determine: a) whether different acids allow for higher concentrations of CET to be
observed utilizing MALDI-TOF mass spectrometry (we should see higher peaks
at the monomeric state, and higher peaks at the dimer base if this is true) and; b)
if water interferes with CET as a pseudo base.
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Table 2
A. Acid
Chelerythrine

0.1N HCL

Concentration

Dilution #

1 μL

9 μL

2.2x10-2 M

Dilution I

1 μL

9 μL

2.2x10-3 M

Dilution II

1 μL

9 μL

2.2x10-4 M

Dilution III

1 μL

9 μL

2.2x10-5 M

Dilution IV

1 μL

9 μL

2.2x10-6 M

Dilution V

Chelerythrine

dH20

B. Base.
Base (NaOH)

1 μL

8 μL

1 μL

2.2x10-2 M

Dilution I

1 μL

8 μLl

1 μL

2.2x10-3 M

Dilution II

1 μL

8 μL

1 μL

2.2x10-4 M

Dilution III

1 μL

8 μL

1 μL

2.2x10-5 M

Dilution IV

1 μL

8 μL

1 μL

2.2x10-6 M

Dilution V

Concentration Dilution #

Samples were spotted on MALDI-TOF plate using CHCA as the matrix. CET
was mixed 1:1 with CHCA in 50% ACN containing 0.1 % 1 μL of the mixture and
spotted on the plate. Figure 7 depicts a sharp reduction in the peak intensities (PI)
of Chelerythrine when introduced to the strong base sodium hydroxide (NaOH)
causing a non-linear relationship between peak intensity and CET concentration.
Hence a right shift of the PI to CET concentration relationship occurred lowering
14

the detection limit by several orders of magnitude. These data are consistent with
a loss of the charged monomer form, presumably due to formation of pseudo base
which is defined as a compound that though not itself containing basic hydroxyl
ion is capable of isomerizing into a true base that does contain hydroxyl ion.
Chelerythrine’s Dependency Upon pH: CET expression (PI) has varied in the
past experiments via serial dilutions. Signs of this are best observed upon adding
a strong base (NaOH) or a strong acid (HCl). Thus, a pH titration curve was
conducted to see where the optimal pH for Chelerythrine lies. See figure 9
Modification of the Structure of Chelerythrine: Previously experiments were
conducted using a strong base. The next step was to see if a structural change
could be observed using a weak base. The weak base of choice was ammonium
bicarbonate (Fisher Scientific, CAS 1066-33-7; LOT 073129). In ammonium
bicarbonate, new peaks were observed around the monomeric and dimeric peaks.
The new peaks were around 14-18 Da less than its previous peak. This could mean
that the compound itself changed structurally by adding and/or removing methyl
groups, i.e. opening or closing the dioxanol ring (See Figure 11). Previous data
obtained from MALDI-TOF showed these peaks (362, 317, etc) without the
addition of the weak base which suggests that the structural changes occur
spontaneously when in solution.
Chelerythrine in Cytosolic Conditions: Previous experiments were all
conducted in non-cytosolic conditions. The purpose of this thesis was to find the
CET compound in the cytosol. This experiment was a prelude to analysis that will
be conducted on the HLEC’s.
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The medium used was DMEM (Dulbecco's Modified Eagle Medium)
completed (Catalog # 10-013-CV; Lot # 10013588; Expiration 12/2013;
Manufacture by MediaTech, Inc.). Four, 2 mL microfuge tubes were obtained and
9 μL of DMEM was added to each tube. The tubes are labeled “CET only, in media,
CET + HCl in media, CET + NaOH in media, and CET + NH4HCO3 in media.”
On parafilm, 1µl of CET was spotted and mixed in a 1:1 ratio with the desired
compound (NaOH, HCl etc.). From that new mixture, 1 μL was added to the
appropriate labeled microfuge tube containing 9 µl DMEM and vortexed for
approximately 15-20 sec at a vortex speed of ten. The same procedure was
conducted for the other compounds. Samples were spotted to MALDI Brushed
Steel Plate. The 4 mixtures were controls of CET itself, CHCA, and DMEM were
also spotted to the MALDI plate. See Figure 14
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Results
A. Chelerythrine Detection by MALFITOF MS: Choice of Matrices
Chelerythrine is a quaternary benzophenanthridine alkaloid that occurs in
at least two forms. Figure 1, modified from Lauf et al 2013, depicts the chemical
structure of CET and its pseudo base, both consisting of four benzene rings A-D.
Ring A has two methoxy groups in position 7 and 8. Ring D has a dioxyalkanol
ring. The monomeric 348 Dalton (Da) form contains an imminium group that is
charged due to an uneven  electron distribution between position N5 and C6
causing a positive charge that attracts anions (A-). Upon mild alkalization, the
charged monomer converts into the uncharged 362 Da pseudo base with an OH
at C6. Strong alkalization and heat give rise to a 695 Da dimer due to an ether
bond between two monomers. A putative 1042 Da trimer, not reported in the
literature, was also seen and may form by a yet unknown mechanism, although
this did not always occur.
To answer the first question whether CET can be measured in an organic
buffer by MALDI-TOF MS, CET was mixed with CHCA matrix and spotted onto a
target plate and analyzed by MALDI-TOF MS as described in the Methods Section.
Figure 2 shows identification of CET as a major ion peak at 348 Da. Another major
ion peak was observed at 695 Da which presumably corresponded to a dimer of
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CET, i.e., double the 348 Da peak (Figure 1). A putative trimer at 1042 Da was
also found (Data not shown).
The next step was to compare the mass spectrum of CET in two different
matrixes, CHCA and DHB to select the best matrix. Figure 3 shows the spectra
of ten-fold dilutions of a 2.2 mM CET stock solution made in CHCA as compared
to the matrix CHCA alone. The peaks of the CHCA matrix were masked at higher
concentrations. However, at subsequent lower concentrations the peaks of
CHCA began to mask the presence of the CET sample and the 348, 362 and 695
DA peaks (not shown) were absent, confirming that CHCA was a better matrix
than DHB. DHB only showed the peaks of interest at higher concentrations,
therefore, it was not a proper match for the desired lower concentrations.
B. Chelerythrine Calibration Curves.
After identifying CET in organic solvents and the best matrix for use in the
MALDI-TOF mass spectrometry, a calibration curve was established. The MALDITOF mass spectrometer is a relative or semi-quantitative method at best. Figure
5A plots peak intensity versus the logarithm of CET concentrations of two
experiments each carried out in triplicates, i.e. an N = 6 for each concentration
point. The mean values are indicated as olive triangles with the error bars defining
the SE values. In Figure 5A, the mean peak intensities are connected by a second
order polynomial function curve corresponding to the equation shown in the Figure.
It can be seen that certainly the values near 10 -6 M contribute strongly to the nonlinearity function of the plot.
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Since the lowest observed data plot showed signs of non-linearity, thus it
was decided to delete the lowest concentration data, resulting in the plot shown in
Figure 5B. From this plot of peak intensity versus the log of CET concentration it
is evident that the three remaining points can be easily fitted to a linear function
with an R2 correlation coefficient of 0.9946 permitting calculation of the unknown
concentrations X by calculating the anti-log of (y-a)/b where y is the peak intensity
of the unknown CET sample and a, the y-intercept, and b, the slope, are defined
by the linear equation.
C. Chelerythrine Determination in Biological Media
Cytosol and crude membrane fractions were prepared as stated in Methods
and exactly as reported recently (Dorney et al, 2013). The data in Figure 5B were
used to calculate the concentration of CET in the cytosol and membrane fraction
of HLEC exposed to 50 μM CET for 30 min at 37 oC shown in Figure 6. Exactly 1
μL of cytosol with a protein concentration of 2 μg/ μL was mixed with 1 μL CHCA
and subjected to MALDI TOF MS analysis. The resulting peak intensities were
inserted into the y value of the linear equation shown in Figure 5B and X calculated
from the exponential quotient x (y-a)/b as shown in Table 4. The table contains the x
values calculated from several calibration curves and taking into account the 41
fold dilution factor the cytosol of HLEC underwent in the preparation of the cytosolic
extract. As can be seen, these values differ by some factors, but in general are all
higher than the CET concentration of 50 μM in the external medium to which the
HLEC were exposed. On the first sight these data mean that CET must accumulate
in the cytosol above diffusion equilibrium. Table 4 also shows the transformation
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of peak intensities obtained with the crude particulate membrane fraction
according to Material and Methods. On a first look it seems that the peak intensities
and hence the moles of CET of the membrane fraction is significantly lower than
that of the cytosol. However, upon comparing the moles of CET normalized to the
measured protein levels, the difference between the two fractions is significantly
smaller suggesting that indeed a large portion of CET had entered the membrane
fraction of HLECs (see Discussion for implications). Thus our Data have shown
that MALDI-TOF MS is a technique well capable to quantify the distribution of the
alkaloid CET across the plasma membrane and into the cytosol, from which
presumably it will be able to binding to and affecting its target molecules such as
the PKC or the NKA.
D. Factors Modifying Chelerythrine Detection by MALDI TOF MS: pH.
The data presented in Figure 34 and 5A,B and Table 4 suggest that
potentially a variety of factors may influence the outcome of a calibration curve and
hence the actual detection of CET in biological fluids. These factors may be pH
and solvent mixtures aside from the chemical stability of the compound. Therefore
a series of experiments were designed to test the role of pH and solvent mixtures
in the development of the peak intensities shown in Figures 5 A and B and to assert
that CET is indeed the molecular species measured by MALDITOF MS.
If, as stated in section A, there is a pH dependent equilibrium of charged
and uncharged (pseudo base) monomers in solution, MALDITOF MS should
reveal a sigmoid decline of the peak intensity at 348 Da (m/z) as function of
increasing pH ultimately leading to the disappearance of the CET molecule
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positively charged by the presence of the imminium group. Pseudo base CET
should be not detected by nature of MALDI TOF. A series of experiments were
conducted to investigate this possibility.
Figure 7 depicts the effect of a strong polar solution (NaOH) on CET. In
comparison to the Data in Figure 4, a right shift to higher concentrations occurred
reducing the detection limit of the alkaloid. The decrease arises from the transition
of the charged to the uncharged CET, perhaps coupled to onset of NaOH
interfering during the time of flight portion of MALDI TOF. High alkaline agents
such as NaOH also decrease peak intensity, in part due to degradation (Herbert
et al. 2011) and in part due to lesser ions being present during the time of flight.
Figure 8A shows peak intensity versus CET concentrations after mixing in
a 1:1 ratio with solutions of different pH values of ten-fold increases by the strong
hydrochloric acid (HCl). Unlike with NaOH potentiating of CET, peak intensity was
observed with increased HCl molarity. In Figure 8B peak intensity is plotted versus
CET concentration under the same conditions, and again potentiating occurred
even after several dilutions. This means that the charged CET preferred more
acidic to neutral conditions with extra H+ available over alkaline conditions.
Figure 9 depicts the effect pH over a wide range of various pH
concentrations. The highest peak intensities observed were at the acidic pH range
and decreased as the pH increased towards the basic level suggesting an inverse
relation of peak intensity versus pH. This agrees with Figures 8A & 8B that
suggests the detection of CET preferred acidic to neutral conditions over alkaline
conditions. At alkaline ranges the graph trended upwards again non-significantly.
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Un unresolved question here is why the CET signal did not disappear as alkaline
pH is supposed to shift the charged to the uncharged species that should not be
detected by MALDI TOF MS. Thus determination of the pK a 8.9, which is close to
the previously published pKa of ~9.0 (Weiss et al 2006), is of limited value since a
large portion of obviously charged CET was still detected by MALDI TOF MS.
Figure 10 depicts a range of acidic ranges containing CET. A presumable
trimer can be observed at 1042 m/z ratio, however the trimer's presence is only
observed under very acidic conditions. Weak acid ranges and neutral to alkaline
ranges do not produce the trimer. If indeed trimers are formed under acidic
conditions they cannot involve C6-hydroxylation-mediated ether bonds, and
suggest a different polymer of the alkaloid. Nevertheless, this figure tells us how
important the pH environment is for CET.
While observing the peaks present in the CET spectrum, a constant peak
appearance was detected at approximately 14 Da less than the 348 Da of CET.
This suggests that CET may become unstable in solution and undergoes a process
known as oxidative demethylation. In Figure 11, the structure on the right displays
an open dioxyalkanol ring leaving a methoxy group and a hydroxide group in its
place, which would document that under certain non-optimal conditions, CET may
become unstable.
To test in more detail for the stability of CET, a tandem mass spectrum was
conducted on the monomer peak at 348 Da alone as shown in Figure 12. As
previously stated, this technique will allow for more powerful elucidation and
greatly reduces any interference. The purpose was to confirm that oxidative
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demethylation is occurring as suggested in Figure 11. There is a consistent loss of
approximately 14 Da commensurate with previous findings discussed earlier of a
loss of multiple CH2/CH3 groups.
The Ion Trap Mass Spectrum was another approach to show that the
monomeric peak of CET did fragment the exact same way under the same
conditions, but with different instrumentation. In Figure 13, the parent peak at ~348
Da fragmented into "child peaks" of 332, 318, and 304 Da (m/z). The ion trap
confirms the process of oxidative demethylation and also shows reproducibility
with other Mass Spectra.
Given this new information, it was of interest to apply these techniques to
CET in biological solutions with known concentrations established in Figures 3 and
Table 4. In Figure 14 it is seen that pH change did not affect the peak intensity of
CET in the cytosol. Oxidative demethylation was not observed as frequently as
found in non-biological conditions (Figures 11-13) suggesting CET was a stable
compound. Peak intensities when introduced to NaOH were originally masked and
peak intensities introduced to HCl were amplified. This phenomenon was not
observed in DMEM media.
Figure 15 shows tandem mass spectra conducted on a CET control, CET
in the cytosol and the membrane revealing that the CET samples in the cytosol
and membrane matched the CET control. The fragments are identical to the control
which confirms the presence of CET in the membrane and cytosol. Table 3 lists
the fragment peaks of CET under the three conditions. The 348 Da peaks
fragmented in the same exact way (+/- 1 Da). Result is now a fingerprint since no
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two molecules or compounds will fragment in the exact same way confirming that
CET in fact was present in both the cytosol and membrane.
The conclusion drawn from the experiments in section D is that pH, solvent
mix and molecular stability are important factors to be considered when
constructing calibration curves and hence determining the exact concentration of
a small molecule such as CET.
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Figure 1

Structure of Chelerythrine
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Figure 1: Structure of Chelerythrine consists of four benzene rings, two methoxy
groups and a dioxyalkanol ring. Taken with copy right permission and modified
from Lauf et al. 2013.
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Figure 2

Figure 2 Mass spectra of CET plotting peak intensity versus m/z ratios. There are
two prominent peaks of interest in the spectra. These peaks are approximately
348, and 695 Da.
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Figure 3

Figure 3:

Portion of mass spectra images of a 10 fold CET stock solution

compared to matrix solution alone.
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Figure 4

CHE LE RYT HRI NE CA LI BRAT I O N CURVE
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Figure 4: A calibration curve displaying the peak intensity obtained by MALDI-TOF
MS versus the concentration of CET from 1.5x10-8 to 1.5 x 10-3 M. Data with an N
of 3 with error bars for the SD values.
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Figure 5
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Figure 5: Calibration plot of peak intensity versus log CET concentration (M).
In panel A4 set of Data points from 2 independent experiments done in triplicates
as function of 4 CET concentrations. In B, the values at 10 -6 M CET were omitted
and a linear function drawn through the remaining data point. The mean values
(olive triangles were significantly different from each other with p<0.05 and <0.005
for 10-4 and 10-3 M CET versus 10-5 M CET, respectively. The r2 value was 0.9946.
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Figure 6

Figure 6: Peak intensity of CET at 348 m/z in the cytosol and membrane
samples. Calculated concentrations and content/protein are given in Table 4.
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Figure 7
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Figure 7: Peak intensity versus CET concentrations after dilution in a strong base,
sodium hydroxide (NaOH).
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Figure 8
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Figure 8: Effect of hydrochloric acid molarity on CET peak intensity. In panel 8A
CET was mixed with HCl concentrations in a 1:1 ratio of ten-fold increases in HCl
molarity. (Figure 8B) shows a calibration curve with peak intensity versus CET
concentration at 348 m/z in the presence of 0.1 N HCl
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Figure 9
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Figure 9: Peak Intensity of CET versus pH between the ranges of 2-12. The
apparent pKa was determined to be ~8.9 by a Boltzmann fitting function.
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Figure 10

m/z

Figure 10: Effect of low pH on CET peak intensity versus m/z ratio (indicated on
the x-axis). In panel a) and b) above there is evidence for a 1042 Da (m/z) species,
probably a trimer of CET.
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Figure 11

Figure 11: Chelerythrine structures proposed to occur in solution. Left: native CET
with one dioxanol ring. Right: CET with proposed opening of the dioxanol ring as
described in Results.
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Figure 12

Figure 12: Depicts a tandem (MS/MS) spectrum of CET with fragmentation of the
parent monomer peak yielding smaller "child" fragments at m/z ratios smaller than
348 Dalton. Panel A represents how CET fragments normally, Panel B represents
how it fragments during tandem MS
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Figure 13

Figure 13: Fragments of the monomer parent CET peak at approximately 332,
318 and 304 Da. Ion Trap Mass Spec directly analyzes the compound in the
absence of matrix.
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Figure 14

Figure 14: Direct peak intensity versus m/z recording of the CET monomer at
348 m/z (Da) present in media. Other compounds that originally had an effect on
CET failed to have the same effect while in cytosolic conditions.
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Figure 15

Figure 15: Tandem mass spectra of CET in the diluted cytosol of HLECs. The
technique causes identical fragmentation of CET in cytosol, membrane, and
control media with about +/- 1 Da deviation. This display eliminates “noise” and
shows the peak of interest and its fragments only.
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Table 3

Table 3 MS/MS Fragmentation of CET by MALDI-TOF MS
Fragments

Authentic CET

CET in Cytosol

CET in Membrane

Fragment I

347.973

347.145

346.88

Fragment II

331.614

331.934

329.131

Fragment III

317.727

317.748

317.711

Fragment IV

304.612

303.556

303.067

Fragment V

291.462

289.805

291.2

Fragment VI

190.79

187.518

187.533

Table 3: MS/MS fragments of the parent peak of CET control and its relation to
the fragment peaks of CET in the cytosol and CET bound membrane (Figure 14).
The fragments of CET in the cytosol and bound to the membrane were identical
(+/- ~1 Da) to the CET control.
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Table 4

Peak

Concentration:

Content:

Intensity

µM

mol/μg protein

External Medium

N.A.*

50

N.A.*

Cytosol

161,555

536

4.25 x 10-12

NA

244

N.A.

35,235

NA

3.97 x 10-12

Sample

(measured)

Cytosol
(predicted)*

Crude Membranes

* Predicted from Nernst Equation based on an assumed Em = -40 mV
Table 4: Cellular concentrations and content of Chelerythrine determined by
MALDI-TOF MS
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Discussion
The first questions addressed in this project were whether CET could be
identified by MALDI-TOF MS, whether it can be identified in a cytosolic or
membrane preparation following experiments with micromolar amounts of CET,
and whether and how factors such as pH and the alkaloids stability affect its
properties and identification. The evidence suggests that CET can be analyzed to
micromolar concentrations using MALDI-TOF MS and Ion Trap MS.
In specific aim 1 it was determined that CET could be analyzed via MALDITOF MS (Figure 2). This was significant given its mass, 348 Da, is relatively low
and at, or near the mass of the matrix peaks. However, CET was distinguished
from the matrix making MALDI-TOF a useful tool to analyze this small molecule.
Other researchers have used HPLC, Western Blot Analysis and other
instrumentation to analyze CET (Chao et al. 1998). However, since one of the
goals of our study was to identify quantitatively CET in cellular extracts, we wanted
a technique that would give us both sensitivity and resolution and to compare our
results with that recently obtained by SERS or surface-enhanced Raman
spectroscopy (Dorney et al, 2013).
For the MS, we obtained calibration curve sensitivity for observing CET
within the micro molar range (Figure 5). Resolution is another problem because
CET may not be in its original form after being exposed to growing cells (oxidative
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demethylation mentioned previously) (Figure 12). That is, it may be degraded,
metabolized or it may form higher order structures such as dimers or trimers with
itself. Such techniques as HPLC are not able to easily identify non-authentic or
modified compounds unless a standard is used. However, MALDI-TOF MS
provides the luxury to analyze a compound to less than a Dalton in mass. The only
exception is SERS which showed a resolution into the nano-molar range based on
specific marker bands of CET (Dorney et al 2013).
Only MALDITOF MS would provide a mechanism for critically identifying
metabolites of CET by LIFT or CID fragmentation of the parent CET compound
and using the fragments produced. The results from the fragmentation produced
several ‘fingerprint’ fragments for comparison with cell-exposed CET (Figures 1315). In retrospect, this was mostly not necessary since CET appeared not to be
metabolized or modified in the cells (Figure 14). The results firmly establish that
MALDI-TOF and Ion Trap MS are uniquely qualified for analyzing CET in cell
extracts.
CET in the Cell
The main goal of this project was to determine if CET could be identified in
either the cytosol or plasma membrane of HLECs treated with a concentration of
50 μM of external CET [CET]o followed by harvesting their cytosol and plasma
membranes. MALDI-TOF MS showed authentic CET in both the cytosol and the
crude plasma membrane fraction (Figure 14). However, the distribution of CET
between the two compartments is interesting. There was a roughly 5 fold greater
peak intensity in the cytosol than in the plasma membrane sample (Figure 4). This
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is a good example of how easily one can be misled by "raw" data, because a
calculation of CET in terms of moles/weight of proteins, i.e. its content, revealed
that CET was present in both fractions at about 4 x 10 -12 moles/μg protein. This
number is just an order of magnitude larger than that recently reported by SERS
technology (5 x 10-13 mol/μg) on the same sample (Dorney et al, 2013).
Interestingly, the cytosolic CET concentration, [CET] i, was 536 μM (Table 3) and
this value appears also to be 10 fold larger than [CET] i measured by the SERS
technique (44 μM) and the [CET] o (50 μM).
The answer for these discrepancies may lie in the fact that the data of this
study were calculated based on the linear slope in the micromolar range, as in
Figure 5B. Even solving for the x-value in the second order polynomial equation
would not provide a much different outcome. As discussed above, MALDITOF MS
is a semi-quantitative technique due to the non-linearity of the signal/ small drug
molecule concentration ranges, as also evident from Figure 5A. In contrast to the
published SERS calibration curve for CET, where a strong marker band at 659 cm 1

prevailed over the entire range of 5-6 orders of magnitude of CET concentrations

as a linear function, pH solvents etc applied to make the dilutions of CET seem to
affect the outcome of a calibration curve, as can be seen easily by comparing CET
in HCl versus NaOH (Figures 7 and 8).
Nevertheless it is interesting to compare the observed [CET]i with that
predicted if one assumes the positively charged drug CET+ would distribute across
the membrane as the Nernst equation predicts: log [CET]i = log [CET]o - Em/61.5.
Given the fact that [CET] o was 50 μM, this means that the predicted [CET] i was
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244 μM, a value only different by a factor of two from the observed [CET] i. Thus
the high [CET]i can be rationalized as due to transfer of CET+, i.e. the cationic
alkaloid following the electrochemical distribution of all cations across the cell
membrane with an assumed Em of -40 mV. How then CET crosses the membrane
and what channel system it uses to do so, is the topic of ongoing work. The main
point, of this discussion is that MALDITOF MS permits detection of the cationic
species of CET across the plasma membrane into the cytosol, which to determine
was a goal of this thesis.
The fragmentation patterns produced by CET with LIFT MS were not found
in the cytosol or plasma membrane. This suggested that CET was not metabolized
by the cells. Alternatively, as this is not an entirely quantitative process, some small
amounts of CET may have been metabolized but were below the level of detection
for MS analysis.
One other possibility is that CET in the cell may undergo oxidative
demethylation in the cytosol but not before it reaches the interior of the cell.
Oxidative demethylation is defined as the process of removing one or more methyl
groups from a molecule, involving the oxidation (electron loss) of one or more
atoms in the substrate (Figure 11). Usually when a methyl group (CH3) is removed,
it can be replaced by a proton (H+). Figure 11 compares the original structure of
CET and one of the proposed structures of CET after it undergoes oxidative
demethylation.
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The Role of pH on CET
During analysis a CET trimer was observed multiple times in the presence
of extra protons in highly acidic conditions (HCl). When not under highly acidic
conditions, the trimer was not present, even at weak acid pH ranges. When under
very alkaline conditions, CET’s intensity significantly decreased from 1.56 million
to 330,000 peak intensity. This finding is partially due to the fact that NaOH
prevents ions from being analyzed via MALDI-TOF MS, however, this result also
shows how CET does not react well with strong alkalizing agents. These
observations provided a hint that CET, which has a charged imminium group,
prefers to keep its charge.
Ion Trapping
Ion Trapping occurs when a non-charged molecule enters the cell, becomes
charged, and then cannot cross back due to the change in pH. There is reason to
believe that ion trapping occurs. The ability for a compound to passively cross the
cell membrane depends on three factors; molecular weight, lipid solubility and
molecular charge.
The build-up of a higher concentration of a chemical across a cell
membrane due to the pKa value of the chemical and difference of pH across the
cell membrane can also occur during ion trapping. The loss of a methyl and
addition of a proton (H+) would increase the pKa of the CET molecule. Once this
occurs, CET may no longer leave the cell and will cause an acidic build up within
the cytosol.
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Quantitation of CET by MALDI-TOF MS
As previously mentioned above in this thesis, MALDI-TOF MS is relative or
semi-quantitative at best. The spectra obtained depends heavily on the ability of
charged ions to reach the detector within the mass spectrometer to generate the
graph. While samples are analyzed, there are times where “sweet,” or “hot” spots
are hit by the laser. This causes a significant increase in the peak intensity.
However, there are also times when the laser (which randomly fires at the sample
spot) will not hit the right spots, thus yielding very low peak intensities.
Due to the relativeness of this approach, establishing a calibration curve
solely with the mass spectrometer proved to be a more difficult process then
predicted. Figure 5 depicts the accepted calibration curve that was established that
was used for determining the cytosolic CET concentration. There are certain linear
ranges of the curve, and there are non-linear ranges as well. It was determined
that the linear micromolar ranges were CET’s optimal level for analysis. Figure 5B
shows the calibration curve that only reflects the linear range.
Although this proved to be a difficult process, the protein content of CET in
the cytosol was obtained with the aid of the calibration curve. Thus we were able
to produce a quantitative graph with a semi-quantitative method after much trial
and error.
Transport of CET across the Plasma Membrane
There are very few mechanisms that have been proposed as to how CET
crosses the plasma membrane into the cell. Some of these mechanisms include
binding to a sterol like receptor, and through active transport via a transporter.
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Currently these are no elucidating facts, only speculations to show how it CET
might cross the membrane.
Figure 16-A

Figure 16-B

Cholesterol (Figure 16A) easily passes through the membrane, and its
structure has many similarities to the original structure of CET (Figure 16B). In a
simplistic mechanism, CET could pass through the plasma membrane to gain
access to the inner lipid bilayer and subsequently cytosol where it can interact with
PKC or the NKA. Chelerythrine, however, has a charge on nitrogen (imminium
group) which makes this pathway unlikelhy..
If CET crosses the cell membrane as a charged molecule, and then
becomes demethylated as mentioned previously; then the CET molecule may no
longer cross the membrane (ion trapping). Due to the effect of ion trapping, the cell
can become loaded with the CET molecule.
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Implications for CET in Medicine
Chelerythrine may see greater use in the treatment of diseases as its real
mechanisms of activity are still being discovered. It has been reported that Herpes
Simplex Virus type 1 infection leads to the recruitment of PKC to the nuclear rim
(Park et al 2006). Chelerythrine is a well-known inhibitor of PKC and other
intracellular enzymes that resides in the equilibrium between the cytosol and the
internal plasma membrane (Herbert et al., 1990). Thus CET can function to block
HSV-1’s ability to recruit PKC since the latter is inhibited. The “loaded” cell
containing this inhibitor could prevent HSV-1 from recruiting PKC to the INM to
phosphorylate lamins (Park et al 2006).
This is crucial because the Herpes Simplex viruses assembles progeny
nucleocapsids within the host cell nucleus. Fully formed DNA-containing
nucleocapsids must then exit the nucleus by budding through the inner and outer
nuclear membranes (Park et al 2006). The potential of this interaction would be
conducive to future studies regarding CET and its potential medicinal applications.
Chelerythrine has also been documented as having potential to become a
new

antibacterial

agent

for

use

against

MRSA

(Methicillin-resistant

Staphylococcus aureus), a multidrug-resistant (MDR) bacterium. The resistance
has increased relentlessly and has been recognized as a global nosocomial
problem in recent years. MRSA is resistant to β-lactams, aminoglycosides,
fluoroquinolones and macrolide, only sensitive to vancomycin, but the isolate of
vancomycin-resistant S. aureus (VRSA) has also been reported (Zuo et al. 2008).
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With Staphylococcus infections growing resistant the most current treatments,
chelerythrine has the promise becoming a new way to combat the disease.
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Conclusions
Chelerythrine was observed in the cytosol (see figure 13), it’s concentration
in the cell was found to be 536 µM well above diffusion equilibrium, suggesting a
membrane potential driven entry of the charged compound.
Chelerythrine already has a charge on the imminium group; however there
is another phenomenon that keeps a charge on the molecule. Dehydrogenation is
defined as a chemical reaction that involves the removal of hydrogen from a
molecule. It is the reverse process of hydrogenation. Removing atoms from the
CET molecule will keep the molecule charged.
Data obtained also suggests that CET does not form an ether-bonded dimer
when in biological conditions. While in DMEM (media) or in HLECs, the dimer was
not present. The dimer’s presence was more readily observed when CET came
into direct contact with an outside chemical such as HCl or NaOH; or when
analyzed directly.
When in biological solutions, HCl’s potentiating effect and NaOH’s inhibition
effect were not observed as prominently as they were in non-biological conditions.
This finding suggests that alteration of the CET compound pre-entry into the
cytosol was not associated with molecular changes.
Mechanistically speaking it has been suggested that CET binds to
glutathione (GSH) due nucleophilic attack by the latter and is transported out of
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the cell via Mrp2 with a 1:1 stoichiometry (Huan et al. 2003). Since there is no
measurable GSH in the external medium, it is unlikely this mechanism is important
for CET entry. It is however possible that CET enters the cell as a charged moiety
through non-selective cation channels.
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Appendix
Raw Data of Chelerythrine (Figure 4)
CET Conc. (M)

Mass/Charge
(m/z)

Time of Flight
(TOF)

Peak Intensity (PI)

347.986

21704.35

1746014.355

347.978

21704.11

2025438.184

347.975

21704.00

1583186.023

347.969

21703.83

1146173.191

347.972

21703.92

474308.081

347.964

21703.68

16341.486

2.2x10-2 mg/mL
2.2x10-3 mg/mL
2.2x10-4 mg/mL
2.2x10-5 mg/mL
2.2x10-6 mg/mL
2.2x10-7 mg/mL

Raw Data of Chelerythrine with HCl (Figure 8B)
CET Conc.
(M)

HCl Conc.
(M)

2.2x10-2

0.1 M

Mass/Charge
(m/z)

Time of Flight
(TOF)

Peak Intensity
(PI)

347.998

21704.73

2699222.709

348.029

21805.67

1754129.869

348.020

21705.39

1987156.380

348.013

21705.18

1558078.530

348.025

21705.56

447465.059

348.005

21704.92

9317.059

mg/mL
2.2x10-3

0.1 M

mg/mL
2.2x10-4

0.1 M

mg/mL
2.2x10-5

0.1 M

mg/mL
2.2x10-6

0.1 M

mg/mL
2.2x10-7

0.1 M

mg/mL

Raw Data of Chelerythrine with NaOH (Figure 7)

Concentration
(M)
2.2x10-2 mg/mL
2.2x10-3 mg/mL
2.2x10-4 mg/mL
2.2x10-5 mg/mL
2.2x10-6 mg/mL

NaOH
Conc.
(M)
0.39 M

Mass/Charge
(m/z)

Time of
Flight (TOF)

Peak Intensity
(PI)

347.994

21704.58

1559902.461

347.969

21703.82

328846.760

347.959

21703.52

29643.234

347.959

21703.50

1670.492

347.965

21703.71

609.834

0.39 M
0.39 M
0.39 M
0.39 M

Power Analysis for Figure 6

Cytosol

Cell Membrane
81096.82

4700.21

141532.42

23641.23

137878.93

37179.22

442856.7

61751.8

51002.46

58522.3

56968.23

15158.11

72237.61

108282.84

108939.3

7790.09

361484.9

95.21

9

9

Average

161555.2633

35235.66778

Standard Deviation

141617.3783

35431.45545

Standard Error

47205.79276

11810.48515

Number (N)

Student t-Test Statistic for Figure 6
H0: µ1=µ2
HA: µ1≠µ2

t-Test: Two-Sample Assuming Unequal Variances

Mean
Variance
Observations
Hypothesized Mean Difference
Df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail

Variable 1
161555.2633
20055481834
9
0
9
2.595920527
0.014465578
1.833112933
0.028931156
2.262157163

Variable 2
35235.66778
1255388035
9

